Fabienne Anjuère
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fabienne Anjuère has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Veronique M. Braud
Université Côte d'Azur, CNRS UMR7275, Inserm U1323, IPMC, Valbonne, France
25 shared publications - Alexandre Bozec
Institut Universitaire de la Face et du Cou, Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France
19 shared publications - Aïda Meghraoui
Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France
19 shared publications - Gilles Poissonnet
Institut Universitaire de la Face et du Cou, Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France
19 shared publications - Roxane Elaldi
Université Côte d’Azur, CNRS UMR7275, INSERM U1323, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France
19 shared publications - Anne Sudaka
Université Côte d’Azur, CNRS UMR7275, INSERM U1323, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France
18 shared publications
Latest Publications
- 21 February 2026
- Published by Elsevier in Mathematical Biosciences
- Vol. 395, 109650
Tumor growth and immune response: On the impact of the space-structuration of the tumor microenvironment
- 21 February 2026
- Published by Elsevier in Mathematical Biosciences
- Vol. 395, 109650
Tumor growth and immune response: On the impact of the space-structuration of the tumor microenvironment
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 6. Cell densities in cSCC from different clinical situations.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 6. Cell densities in cSCC from different clinical situations.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S8 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 8. Cell densities in cSCC from primary cSCC and relapsing cSCC from paired patients.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 8. Cell densities in cSCC from primary cSCC and relapsing cSCC from paired patients.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Table S5 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 5. Statistical differences between the density of the immune cell subsets infiltrating NT epidermis
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 5. Statistical differences between the density of the immune cell subsets infiltrating NT epidermis
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 5. Neighborhood analysis in perilesional NT skin and in cSCC.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 5. Neighborhood analysis in perilesional NT skin and in cSCC.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 3. 39-markers IMC panel for cSCC TiME characterization
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 3. 39-markers IMC panel for cSCC TiME characterization
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 4. Comparative numbers of cells in NT epidermis and cSCC tumor islets.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 4. Comparative numbers of cells in NT epidermis and cSCC tumor islets.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 2. Sizes of cSCC and NT skin ROI
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 2. Sizes of cSCC and NT skin ROI
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 3. Abundance and density of annotated cell subsets in total NT skin and cSCC TiME.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 3. Abundance and density of annotated cell subsets in total NT skin and cSCC TiME.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 4. Human antibody flow cytometry panel for phenotyping macrophages
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 4. Human antibody flow cytometry panel for phenotyping macrophages